New Ground in Antifungal Discovery and Therapy for Invasive Fungal Infections: Innovations, Challenges, and Future Directions

This review explores current advancements and challenges in antifungal therapies amid rising fungal infections, particularly in immunocompromised patients. We detail the limitations of existing antifungal classes—azoles, echinocandins, polyenes, and flucytosine—in managing systemic infections and th...

Full description

Saved in:
Bibliographic Details
Main Authors: Gustavo A. Niño-Vega, Leonardo Padró-Villegas, Everardo López-Romero
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Journal of Fungi
Subjects:
Online Access:https://www.mdpi.com/2309-608X/10/12/871
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846104117007613952
author Gustavo A. Niño-Vega
Leonardo Padró-Villegas
Everardo López-Romero
author_facet Gustavo A. Niño-Vega
Leonardo Padró-Villegas
Everardo López-Romero
author_sort Gustavo A. Niño-Vega
collection DOAJ
description This review explores current advancements and challenges in antifungal therapies amid rising fungal infections, particularly in immunocompromised patients. We detail the limitations of existing antifungal classes—azoles, echinocandins, polyenes, and flucytosine—in managing systemic infections and the urgent need for alternative solutions. With the increasing incidence of resistance pathogens, such as <i>Candida auris</i> and <i>Aspergillus fumigatus</i>, we assess emerging antifungal agents, including Ibrexafungerp, T-2307, and N′-Phenylhydrazides, which target diverse fungal cell mechanisms. Innovations, such as nanoparticles, drug repurposing, and natural products, are also evaluated for their potential to improve efficacy and reduce resistance. We emphasize the importance of novel approaches to address the growing threat posed by fungal infections, particularly for patients with limited treatment options. Finally, we briefly examine the potential use of artificial intelligence (AI) in the development of new antifungal treatments, diagnoses, and resistance prediction, which provides powerful tools in the fight against fungal pathogens. Overall, we highlight the pressing need for continued research to advance antifungal treatments and improve outcomes for high-risk populations.
format Article
id doaj-art-fddd85a4011f4607a8d2b8c5155446f1
institution Kabale University
issn 2309-608X
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Journal of Fungi
spelling doaj-art-fddd85a4011f4607a8d2b8c5155446f12024-12-27T14:34:00ZengMDPI AGJournal of Fungi2309-608X2024-12-01101287110.3390/jof10120871New Ground in Antifungal Discovery and Therapy for Invasive Fungal Infections: Innovations, Challenges, and Future DirectionsGustavo A. Niño-Vega0Leonardo Padró-Villegas1Everardo López-Romero2Departamento de Biología, División de Ciencias Naturales y Exactas, Campus Guanajuato, Universidad de Guanajuato, Noria Alta s/n, col. Noria Alta, Guanajuato C.P. 36050, MexicoDepartamento de Biología, División de Ciencias Naturales y Exactas, Campus Guanajuato, Universidad de Guanajuato, Noria Alta s/n, col. Noria Alta, Guanajuato C.P. 36050, MexicoDepartamento de Biología, División de Ciencias Naturales y Exactas, Campus Guanajuato, Universidad de Guanajuato, Noria Alta s/n, col. Noria Alta, Guanajuato C.P. 36050, MexicoThis review explores current advancements and challenges in antifungal therapies amid rising fungal infections, particularly in immunocompromised patients. We detail the limitations of existing antifungal classes—azoles, echinocandins, polyenes, and flucytosine—in managing systemic infections and the urgent need for alternative solutions. With the increasing incidence of resistance pathogens, such as <i>Candida auris</i> and <i>Aspergillus fumigatus</i>, we assess emerging antifungal agents, including Ibrexafungerp, T-2307, and N′-Phenylhydrazides, which target diverse fungal cell mechanisms. Innovations, such as nanoparticles, drug repurposing, and natural products, are also evaluated for their potential to improve efficacy and reduce resistance. We emphasize the importance of novel approaches to address the growing threat posed by fungal infections, particularly for patients with limited treatment options. Finally, we briefly examine the potential use of artificial intelligence (AI) in the development of new antifungal treatments, diagnoses, and resistance prediction, which provides powerful tools in the fight against fungal pathogens. Overall, we highlight the pressing need for continued research to advance antifungal treatments and improve outcomes for high-risk populations.https://www.mdpi.com/2309-608X/10/12/871antifungal therapydrug resistancefungal infectionsnovel antifungalsnanoparticlesnatural products
spellingShingle Gustavo A. Niño-Vega
Leonardo Padró-Villegas
Everardo López-Romero
New Ground in Antifungal Discovery and Therapy for Invasive Fungal Infections: Innovations, Challenges, and Future Directions
Journal of Fungi
antifungal therapy
drug resistance
fungal infections
novel antifungals
nanoparticles
natural products
title New Ground in Antifungal Discovery and Therapy for Invasive Fungal Infections: Innovations, Challenges, and Future Directions
title_full New Ground in Antifungal Discovery and Therapy for Invasive Fungal Infections: Innovations, Challenges, and Future Directions
title_fullStr New Ground in Antifungal Discovery and Therapy for Invasive Fungal Infections: Innovations, Challenges, and Future Directions
title_full_unstemmed New Ground in Antifungal Discovery and Therapy for Invasive Fungal Infections: Innovations, Challenges, and Future Directions
title_short New Ground in Antifungal Discovery and Therapy for Invasive Fungal Infections: Innovations, Challenges, and Future Directions
title_sort new ground in antifungal discovery and therapy for invasive fungal infections innovations challenges and future directions
topic antifungal therapy
drug resistance
fungal infections
novel antifungals
nanoparticles
natural products
url https://www.mdpi.com/2309-608X/10/12/871
work_keys_str_mv AT gustavoaninovega newgroundinantifungaldiscoveryandtherapyforinvasivefungalinfectionsinnovationschallengesandfuturedirections
AT leonardopadrovillegas newgroundinantifungaldiscoveryandtherapyforinvasivefungalinfectionsinnovationschallengesandfuturedirections
AT everardolopezromero newgroundinantifungaldiscoveryandtherapyforinvasivefungalinfectionsinnovationschallengesandfuturedirections